Aims/hypothesis
An insulin signalling pathway leading from activation of protein kinase B (PKB, also known as Akt) to phosphorylation (inactivation)
of glycogen synthase kinase-3 (GSK-3) and activation of glycogen synthase is well characterised. However, in hepatocytes,
inactivation of GSK-3 is not the main mechanism by which insulin stimulates glycogen synthesis. We therefore tested whether
activation of PKB causes inactivation of glycogen phosphorylase.
Materials and methods
We used a conditionally active form of PKB, produced using recombinant adenovirus, to test the role of acute PKB activation
in the control of glycogen phosphorylase and glycogen synthesis in hepatocytes.
Results
Conditional activation of PKB mimicked the inactivation of phosphorylase, the activation of glycogen synthase, and the stimulation
of glycogen synthesis caused by insulin. In contrast, inhibition of GSK-3 caused activation of glycogen synthase but did not
mimic the stimulation of glycogen synthesis by insulin. PKB activation and GSK-3 inhibition had additive effects on the activation
of glycogen synthase, indicating convergent mechanisms downstream of PKB involving inactivation of either phosphorylase or
GSK-3. Glycogen synthesis correlated inversely with the activity of phosphorylase-a, irrespective of whether this was modulated
by insulin, by PKB activation or by a selective phosphorylase ligand, supporting an essential role for phosphorylase inactivation
in the glycogenic action of insulin in hepatocytes.
Conclusions/interpretation
In hepatocytes, the acute activation of PKB, but not the inhibition of GSK-3, mimics the stimulation of glycogen synthesis
by insulin. This is explained by a pathway downstream of PKB leading to inactivation of phosphorylase, activation of glycogen
synthase, and stimulation of glycogen synthesis, independent of the GSK-3 pathway.
Keywords Akt - Glycogen phosphorylase - Glycogen synthase - Glycogen synthase kinase-3 - Hepatocytes - Insulin - Protein kinase B